| [1] |
姚涛,田柏淋,湛彦强, 等. 急性缺血性脑卒中患者体质量指数与临床预后及病死率的相关性[J]. 实用医学杂志, 2019, 35(20): 3188-3192.
|
| [2] |
WAFA H A, WOLFE C D A, EMMETT E, et al. Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years[J]. Stroke, 2020, 51(8): 2418-2427. DOI: 10.1161/STROKEAHA.120.029606.
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
方兴,江颖,欧俐羽, 等. 脑梗死患者同型半胱氨酸与血脂相关性及其诊断价值[J]. 实用医学杂志, 2017, 33(22): 3819-3821.
|
| [7] |
MENG X L, WEN R Y, LI X. Values of serum LDL and PCT levels in evaluating the condition and prognosis of acute cerebral infarction[J]. Exp Ther Med, 2018, 16(4): 3065-3069. DOI: 10.3892/etm.2018.6522.
|
| [8] |
LIU Q, CUI H Z, MA Y H, et al. Triglyceride-glucose index associated with the risk of cardiovascular disease: the Kailuan study[J]. Endocrine, 2022, 75(2): 392-399. DOI: 10.1007/s12020-021-02862-3.
|
| [9] |
TOH E M S, LIM A Y L, MING C, et al. Association of triglyceride-glucose index with clinical outcomes in patients with acute ischemic stroke receiving intravenous thrombolysis[J]. Sci Rep, 2022, 12(1): 1596. DOI: 10.1038/s41598-022-05467-6.
|
| [10] |
VAN DAM-NOLEN D H K, VAN DIJK A C, CROMBAG G A J C, et al. Lipoprotein(a)levels and atherosclerotic plaque characteristics in the carotid artery: The Plaque at RISK(PARISK)study[J]. Atherosclerosis, 2021, 329: 22-29. DOI: 10.1016/j.atherosclerosis.2021.06.004.
|
| [11] |
LANGSTED A, MADSEN C M, NORDESTGAARD B G. Contribution of remnant cholesterol to cardiovascular risk[J]. J Intern Med, 2020, 288(1): 116-127. DOI: 10.1111/joim.13059.
|
| [12] |
VARBO A, NORDESTGAARD B G. Remnant cholesterol and risk of ischemic stroke in 112, 512 individuals from the general population[J]. Ann Neurol, 2019, 85(4): 550-559. DOI: 10.1002/ana.25432.
|
| [13] |
WADSTRÖM B N, WULFF A B, PEDERSEN K M, et al. Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study[J]. Eur Heart J, 2022, 43(34): 3258-3269. DOI: 10.1093/eurheartj/ehab705.
|
| [14] |
LI W J, HUANG Z G, FANG W, et al. Remnant cholesterol variability and incident ischemic stroke in the general population[J]. Stroke, 2022, 53(6): 1934-1941. DOI: 10.1161/STROKEAHA.121.037756.
|
| [15] |
LI H, MIAO S, CHEN L, et al. Association and mediating mechanism between remnant cholesterol and first-ever stroke among the Chinese general population[J]. Front Neurosci, 2023, 17: 1161367. DOI: 10.3389/fnins.2023.1161367.
|
| [16] |
SHAO Q Y, YANG Z Q, WANG Y F, et al. Elevated remnant cholesterol is associated with adverse cardiovascular outcomes in patients with acute coronary syndrome[J]. J Atheroscler Thromb, 2022, 29(12): 1808-1822. DOI: 10.5551/jat.63397.
|
| [17] |
SAEED A, FEOFANOVA E V, YU B, et al. Remnant-like particle cholesterol, low-density lipoprotein triglycerides, and incident cardiovascular disease[J]. J Am Coll Cardiol, 2018, 72(2): 156-169. DOI: 10.1016/j.jacc.2018.04.050.
|
| [18] |
WANG Y Q, ZHA F B, HAN Y, et al. Nonlinear connection between remnant cholesterol and stroke risk: evidence from the China health and retirement longitudinal study[J]. Lipids Health Dis, 2023, 22(1): 181. DOI: 10.1186/s12944-023-01943-8.
|
| [19] |
LIU C X, DAI M, TIAN K M, et al. Association of remnant cholesterol with CVD incidence: a general population cohort study in southwest China[J]. Front Cardiovasc Med, 2023, 10: 1286286. DOI: 10.3389/fcvm.2023.1286286.
|
| [20] |
|
| [21] |
TAN Z, ZHANG Q Y, LIU Q W, et al. Relationship between remnant cholesterol and short-term prognosis in acute ischemic stroke patients[J]. Brain Behav, 2024, 14(5): e3537. DOI: 10.1002/brb3.3537.
|
| [22] |
WU Z Y, ZHANG H P, XU Y, et al. Low remnant cholesterol and in-hospital bleeding risk after ischemic stroke or transient ischemic attack[J]. J Am Heart Assoc, 2024, 13(14): e034307. DOI: 10.1161/JAHA.124.034307.
|
| [23] |
ZHOU L, MAI J Z, LI Y, et al. Triglyceride to high-density lipoprotein cholesterol ratio and risk of atherosclerotic cardiovascular disease in a Chinese population[J]. Nutr Metab Cardiovasc Dis, 2020, 30(10): 1706-1713. DOI: 10.1016/j.numecd.2020.05.009.
|
| [24] |
SATO F, NAKAMURA Y, KAYABA K, et al. TG/HDL-C ratio as a predictor of stroke in the population with healthy BMI: The Jichi Medical School Cohort Study[J]. Nutr Metab Cardiovasc Dis, 2022, 32(8): 1872-1879. DOI: 10.1016/j.numecd.2022.05.002.
|
| [25] |
ZHANG S K, CAO C C, HAN Y, et al. A nonlinear relationship between the triglycerides to high-density lipoprotein cholesterol ratio and stroke risk: an analysis based on data from the China Health and Retirement Longitudinal Study[J]. Diabetol Metab Syndr, 2024, 16(1): 96. DOI: 10.1186/s13098-024-01339-3.
|
| [26] |
TIAN Y N, LU L, ZHANG Y Z, et al. The value of Lp(a)and TG/HDLC in peripheral blood to assess the stability of carotid plaque in patients with ischemic stroke[J]. Brain Behav, 2024, 14(1): e3355. DOI: 10.1002/brb3.3355.
|
| [27] |
CHENG Y Q, ZHU H H, CHEN J, et al. Serum TG/HDL-C level at the acute phase of ischemic stroke is associated with post-stroke cognitive impairment[J]. Neurol Sci, 2022, 43(10): 5977-5984. DOI: 10.1007/s10072-022-06267-6.
|
| [28] |
DENG Q W, WANG H, SUN C Z, et al. Triglyceride to high-density lipoprotein cholesterol ratio predicts worse outcomes after acute ischaemic stroke[J]. Eur J Neurol, 2017, 24(2): 283-291. DOI: 10.1111/ene.13198.
|
| [29] |
DENG M Z, SONG K P, XU W, et al. Association of higher triglyceride-glucose index and triglyceride-to-high-density lipoprotein cholesterol ratio with early neurological deterioration after thrombolysis in acute ischemic stroke patients[J]. Front Neurol, 2024, 15: 1421655. DOI: 10.3389/fneur.2024.1421655.
|
| [30] |
HUANG Z G, DING X, YUE Q, et al. Triglyceride-glucose index trajectory and stroke incidence in patients with hypertension: a prospective cohort study[J]. Cardiovasc Diabetol, 2022, 21(1): 141. DOI: 10.1186/s12933-022-01577-7.
|
| [31] |
ZHANG B X, LEI H H, AMBLER G, et al. Association between triglyceride-glucose index and early neurological outcomes after thrombolysis in patients with acute ischemic stroke[J]. J Clin Med, 2023, 12(10): 3471. DOI: 10.3390/jcm12103471.
|
| [32] |
LIN S F, HU H H, CHAO H L, et al. Triglyceride-glucose index and intravenous thrombolysis outcomes for acute ischemic stroke: a multicenter prospective-cohort study[J]. Front Neurol, 2022, 13: 737441. DOI: 10.3389/fneur.2022.737441.
|
| [33] |
WILSON P W F, JACOBSON T A, MARTIN S S, et al. Lipid measurements in the management of cardiovascular diseases: practical recommendations a scientific statement from the national lipid association writing group[J]. J Clin Lipidol, 2021, 15(5): 629-648. DOI: 10.1016/j.jacl.2021.09.046.
|
| [34] |
IMAMURA T, DOI Y, NINOMIYA T, et al. Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the hisayama Study[J]. Atherosclerosis, 2014, 233(2): 343-348. DOI: 10.1016/j.atherosclerosis.2014.01.005.
|
| [35] |
ZHAO Z, WANG H R, HOU Q, et al. Non-traditional lipid parameters as potential predictors of carotid plaque vulnerability and stenosis in patients with acute ischemic stroke[J]. Neurol Sci, 2023, 44(3): 835-843. DOI: 10.1007/s10072-022-06472-3.
|
| [36] |
WANG B Y, WANG J M, LIU C X, et al. The potential of platelet to high-density lipoprotein cholesterol ratio(PHR)as a novel biomarker for heart failure[J]. Sci Rep, 2024, 14(1): 23283. DOI: 10.1038/s41598-024-75453-7.
|
| [37] |
HOU X, ZHU M B, ZHU Z H, et al. Association between platelet-to-high-density lipoprotein cholesterol ratio and future stroke risk: a national cohort study based on CHARLS[J]. Front Neurol, 2024, 15: 1479245. DOI: 10.3389/fneur.2024.1479245.
|
| [38] |
SHEN H M, HUANG A Y, WANG B X, et al. Clinical value of Lp-PLA2, LDL-C, HDL-C, hs-CRP, leukocyte, FPG and HbA 1c in type 2 diabetes mellitus patients with acute ischemic stroke[J]. Front Endocrinol(Lausanne), 2025, 16: 1546961. DOI: 10.3389/fendo.2025.1546961.
|
| [39] |
ZHAO T, GONG H P, DONG Z Q, et al. Predictive value of fasting blood glucose for serious coronary atherosclerosis in non-diabetic patients[J]. J Int Med Res, 2019, 47(1): 152-158. DOI: 10.1177/0300060518798252.
|
| [40] |
ZHANG H L, CHEN X, ZONG B B, et al. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation[J]. J Cell Mol Med, 2018, 22(9): 4437-4448. DOI: 10.1111/jcmm.13743.
|
| [41] |
SHAH M S, BROWNLEE M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes[J]. Circ Res, 2016, 118(11): 1808-1829. DOI: 10.1161/CIRCRESAHA.116.306923.
|